vs
Penumbra Inc（PEN）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是Penumbra Inc的1.2倍（$461.6M vs $385.4M），RBC Bearings INC净利率更高（14.6% vs 12.3%，领先2.3%），Penumbra Inc同比增速更快（22.1% vs 17.0%），RBC Bearings INC自由现金流更多（$99.1M vs $68.0M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 5.6%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
PEN vs RBC — 直观对比
营收规模更大
RBC
是对方的1.2倍
$385.4M
营收增速更快
PEN
高出5.1%
17.0%
净利率更高
RBC
高出2.3%
12.3%
自由现金流更多
RBC
多$31.1M
$68.0M
两年增速更快
PEN
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $461.6M |
| 净利润 | $47.3M | $67.4M |
| 毛利率 | 68.0% | 44.3% |
| 营业利润率 | 15.4% | 22.3% |
| 净利率 | 12.3% | 14.6% |
| 营收同比 | 22.1% | 17.0% |
| 净利润同比 | 40.6% | 16.4% |
| 每股收益（稀释后） | $1.20 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENRBC
| Q4 25 | $385.4M | $461.6M | ||
| Q3 25 | $354.7M | $455.3M | ||
| Q2 25 | $339.5M | $436.0M | ||
| Q1 25 | $324.1M | $437.7M | ||
| Q4 24 | $315.5M | $394.4M | ||
| Q3 24 | $301.0M | $397.9M | ||
| Q2 24 | $299.4M | $406.3M | ||
| Q1 24 | $278.7M | $413.7M |
净利润PENRBC
| Q4 25 | $47.3M | $67.4M | ||
| Q3 25 | $45.9M | $60.0M | ||
| Q2 25 | $45.3M | $68.5M | ||
| Q1 25 | $39.2M | $72.7M | ||
| Q4 24 | $33.7M | $57.9M | ||
| Q3 24 | $29.5M | $54.2M | ||
| Q2 24 | $-60.2M | $61.4M | ||
| Q1 24 | $11.0M | — |
毛利率PENRBC
| Q4 25 | 68.0% | 44.3% | ||
| Q3 25 | 67.8% | 44.1% | ||
| Q2 25 | 66.0% | 44.8% | ||
| Q1 25 | 66.6% | 44.2% | ||
| Q4 24 | 66.8% | 44.3% | ||
| Q3 24 | 66.5% | 43.7% | ||
| Q2 24 | 54.4% | 45.3% | ||
| Q1 24 | 65.0% | 43.1% |
营业利润率PENRBC
| Q4 25 | 15.4% | 22.3% | ||
| Q3 25 | 13.8% | 21.5% | ||
| Q2 25 | 12.0% | 23.2% | ||
| Q1 25 | 12.4% | 23.0% | ||
| Q4 24 | 13.6% | 21.7% | ||
| Q3 24 | 11.7% | 21.6% | ||
| Q2 24 | -27.0% | 24.0% | ||
| Q1 24 | 4.3% | 22.8% |
净利率PENRBC
| Q4 25 | 12.3% | 14.6% | ||
| Q3 25 | 12.9% | 13.2% | ||
| Q2 25 | 13.3% | 15.7% | ||
| Q1 25 | 12.1% | 16.6% | ||
| Q4 24 | 10.7% | 14.7% | ||
| Q3 24 | 9.8% | 13.6% | ||
| Q2 24 | -20.1% | 15.1% | ||
| Q1 24 | 3.9% | — |
每股收益（稀释后）PENRBC
| Q4 25 | $1.20 | $2.13 | ||
| Q3 25 | $1.17 | $1.90 | ||
| Q2 25 | $1.15 | $2.17 | ||
| Q1 25 | $1.00 | $2.33 | ||
| Q4 24 | $0.88 | $1.82 | ||
| Q3 24 | $0.75 | $1.65 | ||
| Q2 24 | $-1.55 | $1.90 | ||
| Q1 24 | $0.28 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $107.6M |
| 总债务越低越好 | — | $990.2M |
| 股东权益账面价值 | $1.4B | $3.3B |
| 总资产 | $1.8B | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资PENRBC
| Q4 25 | $186.9M | $107.6M | ||
| Q3 25 | $321.0M | $91.2M | ||
| Q2 25 | $421.8M | $132.9M | ||
| Q1 25 | $376.1M | $36.8M | ||
| Q4 24 | $324.4M | — | ||
| Q3 24 | $280.5M | — | ||
| Q2 24 | $288.3M | $76.8M | ||
| Q1 24 | $223.1M | $63.5M |
总债务PENRBC
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益PENRBC
| Q4 25 | $1.4B | $3.3B | ||
| Q3 25 | $1.4B | $3.2B | ||
| Q2 25 | $1.3B | $3.1B | ||
| Q1 25 | $1.2B | $3.0B | ||
| Q4 24 | $1.2B | $2.9B | ||
| Q3 24 | $1.1B | $2.9B | ||
| Q2 24 | $1.2B | $2.8B | ||
| Q1 24 | $1.2B | $2.8B |
总资产PENRBC
| Q4 25 | $1.8B | $5.1B | ||
| Q3 25 | $1.7B | $5.1B | ||
| Q2 25 | $1.7B | $4.8B | ||
| Q1 25 | $1.6B | $4.7B | ||
| Q4 24 | $1.5B | $4.7B | ||
| Q3 24 | $1.5B | $4.7B | ||
| Q2 24 | $1.5B | $4.7B | ||
| Q1 24 | $1.6B | $4.7B |
负债/权益比PENRBC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $99.1M |
| 自由现金流率自由现金流/营收 | 17.7% | 21.5% |
| 资本支出强度资本支出/营收 | 4.8% | 5.0% |
| 现金转化率经营现金流/净利润 | 1.83× | 1.81× |
| 过去12个月自由现金流最近4个季度 | $174.9M | — |
8季度趋势，按日历期对齐
经营现金流PENRBC
| Q4 25 | $86.5M | $122.1M | ||
| Q3 25 | $58.3M | $88.4M | ||
| Q2 25 | $44.9M | $120.0M | ||
| Q1 25 | $49.0M | — | ||
| Q4 24 | $51.1M | $84.0M | ||
| Q3 24 | $56.5M | — | ||
| Q2 24 | $22.6M | $97.4M | ||
| Q1 24 | $38.3M | — |
自由现金流PENRBC
| Q4 25 | $68.0M | $99.1M | ||
| Q3 25 | $42.0M | $71.7M | ||
| Q2 25 | $29.4M | $104.3M | ||
| Q1 25 | $35.5M | — | ||
| Q4 24 | $45.7M | $73.6M | ||
| Q3 24 | $51.0M | — | ||
| Q2 24 | $18.1M | $88.4M | ||
| Q1 24 | $32.5M | — |
自由现金流率PENRBC
| Q4 25 | 17.7% | 21.5% | ||
| Q3 25 | 11.8% | 15.7% | ||
| Q2 25 | 8.7% | 23.9% | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | 14.5% | 18.7% | ||
| Q3 24 | 16.9% | — | ||
| Q2 24 | 6.0% | 21.8% | ||
| Q1 24 | 11.7% | — |
资本支出强度PENRBC
| Q4 25 | 4.8% | 5.0% | ||
| Q3 25 | 4.6% | 3.7% | ||
| Q2 25 | 4.6% | 3.6% | ||
| Q1 25 | 4.2% | 3.2% | ||
| Q4 24 | 1.7% | 2.6% | ||
| Q3 24 | 1.8% | 4.1% | ||
| Q2 24 | 1.5% | 2.2% | ||
| Q1 24 | 2.1% | — |
现金转化率PENRBC
| Q4 25 | 1.83× | 1.81× | ||
| Q3 25 | 1.27× | 1.47× | ||
| Q2 25 | 0.99× | 1.75× | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.52× | 1.45× | ||
| Q3 24 | 1.91× | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | 3.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
